Clinical trial

Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of…

NCT00445055 · University Hospital, Bordeaux, Other · Terminated

Key facts

NCT number NCT00445055
Title Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative Nausea
Official title Study of Evaluation of the Profile of Efficiency / Tolerance of 2 Doses of Intravenous Droperidol in the Prevention of the Postoperative Nausea and Vomits Related to the Surgery of the Thyroid
Acronym DIPAVO
Lead sponsor University Hospital, Bordeaux, Other
Collaborators Kyowa Kirin Co., Ltd. Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Nausea, Vomiting
Intervention type Drug
Interventions Droperidol
Enrollment 71
Start date Apr 1, 2007
Primary completion Apr 1, 2009
Completion Apr 1, 2009
First posted Mar 8, 2007
Last update posted Dec 13, 2011
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies